Recent studies report that the C-reactive protein/albumin ratio (CAR), as a novel inflammation biomarker, has shown independent prognostic effect in various types of cancer, including hepatocellular carcinoma [17], renal cell carcinoma [18], esophageal cancer [19], and colorectal cancer [20]. The gene discussed is CRP; the disease is cancer.